Skip to main content

Evommune, Inc 8-K, filed Nov 12, 2026

Evommune, Inc. (EVMN)

8-K 2026-11-12 For: 2026-11-12
View Original
Added on November 13, 2026

About this 8-K

Evommune, Inc filed this 8-K on November 12, 2026.

Evommune licensed EVO570 from Hinova for $30 million upfront and raised approximately $30 million through a private placement, reporting $262.3 million in cash, cash equivalents and investments and cash runway into 2H 2029. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 7.01: Regulation FD disclosure
  • Item 9.01: Financial statements and exhibits